NewslettersOrganoid NewsHigh-Dose Short-Term Osimertinib Treatment Is Effective in Patient-Derived Metastatic Colorectal Cancer OrganoidsBy Noshin Noorjahan - April 11, 2024037Researchers investigated the cytotoxic anti-tumor effect of high-dose, short-term tyrosine kinase inhibitor treatment on five patient-derived tumor organoids.[BJC Reports]Full Article